1. Home
  2. GRCE
  3. GRCE News

Latest GRACE THERAPEUTICS INC (GRCE) News on July 3, 2025

GRCE: NDA Submitted
GRCE

Zacks Small Cap Research

7 days ago

GRCE: NDA Submitted

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104
GRCE

GlobeNewswire

8 days ago

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104

Grace Therapeutics, Inc. (NASDAQ:GRCE) Is Expected To Breakeven In The Near Future
GRCE

Simply Wall St.

9 days ago

Grace Therapeutics, Inc. (NASDAQ:GRCE) Is Expected To Breakeven In The Near Future

Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update
GRCE

GlobeNewswire

10 days ago

Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update

Grace Therapeutics to Participate in the 2025 BIO International Conference
GRCE

GlobeNewswire

20 days ago

Grace Therapeutics to Participate in the 2025 BIO International Conference

GRCE: Progress Report
GRCE

Zacks Small Cap Research

a month ago

GRCE: Progress Report

This Grace Therapeutics Insider Increased Their Holding By 12% Last Year
GRCE

Simply Wall St.

a month ago

This Grace Therapeutics Insider Increased Their Holding By 12% Last Year

GRCE

MT Newswires

2 months ago

TD Cowen Initiates Coverage on Grace Therapeutics With Buy Rating, $12 Price Target

Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
GRCE

GlobeNewswire

3 months ago

Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
GRCE

GlobeNewswire

4 months ago

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
GRCE

GlobeNewswire

4 months ago

Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

GRCE

Zacks Small Cap Research

4 months ago

GRCE: STRIVE-ON Results Reported

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update
GRCE

GlobeNewswire

5 months ago

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update

Grace Therapeutics secures $15m for GTx-104 pre-commercial development
GRCE

Pharmaceutical Technology

5 months ago

Grace Therapeutics secures $15m for GTx-104 pre-commercial development

GRCE

MT Newswires

5 months ago

Grace Therapeutics Shares Rise After Private Placement Financing of up to $30 Million

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study
GRCE

Benzinga

5 months ago

Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study

Grace Therapeutics Announces Private Placement Financing of up to $30 Million
GRCE

GlobeNewswire

5 months ago

Grace Therapeutics Announces Private Placement Financing of up to $30 Million

Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
GRCE

GlobeNewswire

5 months ago

Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH

3 US Penny Stocks With Market Cap Under $70M
GRCE

Simply Wall St.

5 months ago

3 US Penny Stocks With Market Cap Under $70M

Grace Therapeutics to Participate in Upcoming Investor Events January 2025
GRCE

GlobeNewswire

6 months ago

Grace Therapeutics to Participate in Upcoming Investor Events January 2025

Grace Therapeutics And 2 Other US Penny Stocks Worth Watching
GRCE

Simply Wall St.

6 months ago

Grace Therapeutics And 2 Other US Penny Stocks Worth Watching

GRCE: aSAH KOL Summary
GRCE

Zacks Small Cap Research

7 months ago

GRCE: aSAH KOL Summary

Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference
GRCE

GlobeNewswire

7 months ago

Grace Therapeutics to Exhibit at the American Society of Health-System Pharmacists Conference

GRCE

Zacks Small Cap Research

7 months ago

GRCE: FY:25 Second Quarter Results

Grace Therapeutics And 2 Other US Penny Stocks To Watch
GRCE

Simply Wall St.

8 months ago

Grace Therapeutics And 2 Other US Penny Stocks To Watch

Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update
GRCE

GlobeNewswire

8 months ago

Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update

GRCE: Initiating Coverage – From Confusion to Infusion
GRCE

Zacks Small Cap Research

8 months ago

GRCE: Initiating Coverage – From Confusion to Infusion

Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024
GRCE

GlobeNewswire

8 months ago

Grace Therapeutics to Host Virtual KOL Event on GTx-104 in aneurysmal Subarachnoid Hemorrhage on November 20, 2024

Share on Social Networks: